News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,936 Results
Type
Article (46051)
Company Profile (216)
Press Release (548669)
Section
Business (172096)
Career Advice (2509)
Deals (31765)
Drug Delivery (111)
Drug Development (75885)
Employer Resources (156)
FDA (16105)
Job Trends (13227)
News (304370)
Policy (31747)
Tag
Academia (2353)
Alliances (43025)
Alzheimer's disease (1302)
Approvals (16014)
Artificial intelligence (134)
Bankruptcy (313)
Best Places to Work (9834)
Biotechnology (115)
Breast cancer (120)
Cancer (1075)
Cardiovascular disease (97)
Career advice (2098)
Cell therapy (240)
Clinical research (60329)
Collaboration (365)
Compensation (204)
COVID-19 (2593)
C-suite (94)
Data (1060)
Diabetes (157)
Diagnostics (5358)
Drug pricing (99)
Earnings (67292)
Employer resources (142)
Events (89146)
Executive appointments (293)
FDA (16643)
Funding (305)
Gene therapy (188)
GLP-1 (664)
Government (3879)
Healthcare (15359)
Infectious disease (2680)
Inflammatory bowel disease (106)
Interviews (459)
IPO (14879)
Job creations (3753)
Job search strategy (1762)
Layoffs (457)
Legal (7652)
Lung cancer (177)
Manufacturing (185)
Medical device (11281)
Medtech (11285)
Mergers & acquisitions (16971)
Metabolic disorders (457)
Neuroscience (1588)
NextGen Class of 2024 (5262)
Non-profit (3311)
Northern California (1396)
Obesity (268)
Opinion (212)
Patents (106)
People (50144)
Phase I (18057)
Phase II (26265)
Phase III (20867)
Pipeline (464)
Policy (88)
Postmarket research (2539)
Preclinical (7491)
Radiopharmaceuticals (221)
Rare diseases (224)
Real estate (5192)
Regulatory (21581)
Research institute (2179)
Resumes & cover letters (415)
Southern California (1207)
Startups (3231)
United States (12425)
Vaccines (625)
Weight loss (219)
Date
Today (1)
Last 7 days (639)
Last 30 days (3317)
Last 365 days (33595)
2024 (30879)
2023 (37224)
2022 (47706)
2021 (51390)
2020 (48654)
2019 (39203)
2018 (29907)
2017 (30549)
2016 (29178)
2015 (32679)
2014 (26564)
2013 (22193)
2012 (23752)
2011 (24430)
2010 (22347)
Location
Africa (757)
Arizona (152)
Asia (36659)
Australia (5991)
California (3087)
Canada (1106)
China (222)
Colorado (141)
Connecticut (162)
Europe (83587)
Florida (438)
Georgia (101)
Illinois (289)
Indiana (168)
Maryland (552)
Massachusetts (2461)
Michigan (125)
Minnesota (222)
New Jersey (908)
New York (872)
North Carolina (693)
Northern California (1396)
Ohio (114)
Pennsylvania (769)
South America (1131)
Southern California (1207)
Texas (424)
Washington State (339)
594,936 Results for "ferring pharmaceuticals a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Ferring Pharmaceuticals and Posterity Health Launch New Partnership to Activate Men About Their Fertility
Ferring Pharmaceuticals today launched a new Male Fertility program on Ferring’s Fertility Out Loud platform that empowers men to take the initiative to understand their fertility status.
June 20, 2024
·
4 min read
Press Releases
Genpact Announces Renewed Partnership with Ferring Pharmaceuticals
November 21, 2024
·
2 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
Press Releases
Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
October 3, 2024
·
9 min read
News
Ferring Pharmaceuticals Illustrates Strong Commitment to Advancing Fertility Care at 2024 American Society for Reproductive Medicine Annual Congress
October 18, 2024
·
3 min read
Pharm Country
Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
Ferring Pharmaceuticals today announced the presentation of two analyses of data at the American Society of Pain and Neuroscience (ASPN) 2024 Annual Meeting, for SI-6603, an investigational therapy intended to treat radicular leg pain associated with lumbar disc herniation (LDH).
June 24, 2024
·
3 min read
Pharm Country
Ferring Announces Full Availability of ADSTILADRIN® (nadofaragene firadenovec-vncg) in the U.S.
Ferring Pharmaceuticals announced that ADSTILADRIN® is now fully available across the U.S. for healthcare providers to prescribe for their adult patients with high-risk Bacillus Calmette-Guérin -unresponsive non-muscle invasive bladder cancer with carcinoma in situ with or without papillary tumors.
January 16, 2024
·
7 min read
BioCapital
ASRM Announces Historic $5 Million Endowment From Ferring Pharmaceuticals
The American Society for Reproductive Medicine and Ferring Pharmaceuticals announced a historic $5 million endowment from Ferring to ASRM.
October 16, 2023
·
3 min read
Press Releases
Ferring Presents New Data Analyses for REBYOTA® (fecal microbiota, live – jslm) at ACG 2024
October 28, 2024
·
9 min read
Pharm Country
Ferring Adds Three New Studies to Non-Muscle Invasive Bladder Cancer Clinical Trial Program With ADSTILADRIN® (nadofaragene firadenovec-vncg)
Ferring Pharmaceuticals today announced start up of new studies in the United States (U.S.) for three new ADSTILADRIN in BLadder cancEr (ABLE) clinical trials in patients with non-muscle invasive bladder cancer (NMIBC) with plans to expand select clinical trials outside of the U.S. later this year.
April 16, 2024
·
9 min read
1 of 59,494
Next
